Brain’s Nicotine Center Found

Researchers pinpoint the interpeduncular nucleus as the home of nicotine withdrawal, suggesting that treatments targeted to region may aid smoking cessation.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, ESTRES BACHMONTA brain region called the interpeduncular nucleus, nestled deep within the midbrain, is the seat of nicotine withdrawal, according to new research in mice. Andrew Tapper of the University of Massachusetts Medical School and his colleagues used light to stimulate GABAergic neurons within the interpeduncular nucleus to elicit withdrawal symptoms even in mice who had not been exposed to nicotine. “We were surprised to find that one population of neurons within a single brain region could actually control physical nicotine withdrawal behaviors,” Tapper told the Melbourne Herald Sun.

Tapper and his collaborators habituated mice to nicotine by spiking their water with the drug for six weeks. When the researchers then withheld nicotine from those mice, they exhibited the classic symptoms of withdrawal—excessive scratching and shaking among them. They then noted increased activity in GABAergic neurons in the interpeduncular nucleus, which is linked to feelings of anxiety and receives sensory input from a variety of other brain regions. Topper and his colleagues could even replicate nicotine withdrawal symptoms by exciting neurons in the interpeduncular nucleus in mice who had never been exposed to the drug. And they could dampen withdrawal symptoms by dampening the excitability of GABAergic neurons during withdrawal. They published their findings yesterday (November 14) in Current Biology.

The results hint that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies